CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-18 | ROBIN HOWARD W President & CEO | Sale | −418 | $71.98 | $30K | 54,627 |
| 2026-07-24 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +57,200 | 57,200 | ||
| 2026-06-17 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −5,500 | $60.81 | $334K | 59,545 |
| 2026-06-17 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −4,500 | $61.65 | $277K | 55,045 |
| 2026-06-16 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −5,303 | $59.97 | $318K | 69,742 |
| 2026-06-16 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −4,697 | $60.71 | $285K | 65,045 |
| 2026-05-19 | ROBIN HOWARD W President & CEO | Sale | −444 | $65.51 | $29K | 75,045 |
| 2026-02-18 | ROBIN HOWARD W President & CEO | Sale | −423 | $73.00 | $31K | 75,489 |
| 2025-12-22 | ROBIN HOWARD W President & CEO | Grant or award | +21,667 | 75,912 | ||
| 2025-12-22 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +86,667 | 86,667 | ||
| 2025-11-25 | ROBIN HOWARD W President & CEO | Sale | −2,207 | $54.28 | $120K | 54,245 |
| 2025-11-21 | ROBIN HOWARD W President & CEO | Grant or award | +7,110 | 56,452 | ||
| 2025-11-21 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +12,170 | 12,170 | ||
| 2025-09-09 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −2,100 | $45.16 | $95K | 53,908 |
| 2025-09-09 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −1,200 | $46.41 | $56K | 52,708 |
| 2025-09-09 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −2,156 | $47.49 | $102K | 50,552 |
| 2025-09-09 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −1,210 | $48.18 | $58K | 49,342 |
| 2025-09-05 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −3,304 | $37.87 | $125K | 59,370 |
| 2025-09-05 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −2,226 | $38.82 | $86K | 57,144 |
| 2025-09-05 | ROBIN HOWARD W President & CEO | Sale 10b5-1 | −1,136 | $39.89 | $45K | 56,008 |
Page 1 of 7 · 127 trades